Research theme for competitive and other funds (7)：
2017 - 2019 川崎病特異物質に焦点を当てた川崎病の新規診断法の開発
2014 - 2016 川崎病の病因・病態解明に基づく新規治療・予防法の開発
Genetic background of type 1 diabetes
Stem cell research with cord blood
Study on Gene therapy
Study on Genetic disorders
Study on Pediatric Immunology
Show all
Papers (36)：
Thiha K, Mashimo Y, Suzuki H, Hamada H, Hata A, Hara T, Tanaka T, Ito K, Onouchi Y. Investigation of novel variations of ORAI1 gene and their association with Kawasaki disease. J Hum Genet. 2019. doi: 10.1038/s10038-019-0588-2
Kageyama S, Asakawa M, Takeshita T, Ihara Y, Kanno S, Hara T, Takahashi I, Yamashita Y. Transition of bacterial diversity and composition in tongue microbiota during the first 2 years of life. mSphere. 2019
Kinjo T, Inoue H, Fujiyoshi J, Kusuda T, Koga Y, Takahata Y, Ochiai M, Honjo S, Hara T, Ohga S. Chemokine levels predict progressive liver disease in Down syndrome patients with transient abnormal myelopoiesis. Pediatr Neonatol. 2018. https://doi.org/10.1016/j.pedn
Sugitani Y, Furuno K, Sueishi K, Hara T. Macrophages and cytotoxic T cells infiltrate the destructed mitral tissue in Kawasaki disease. BMJ Case Rep. 2018
Kawasaki disease: Recent advances in the pathophysiology
(The 9th Asian Congress of Pediatric Infectious Diseases 2018)
The pathogenesis/pathophysiology of Kawasaki disease: a keynote address.
(The 12th International Kawasaki Disease Symposium, 2018)
Development of coronary artery lesions in Kawasaki disease was associated with certain Kawasaki disease-specific molecules.
(The 20th International Vascular Biology Meeting 2018 (IVBM2018) 2018)
Calcineurin inhibitors exacerbate Nod1-mediated coronary arteritis via the MyD88 signaling pathway.
(The 13th Congress of the Asian Society for Pediatric Research 2017)
Cardiovascular sequelae of Kawasaki disease at a single hospital between 1982 and 2016.
(The 13th Congress of the Asian Society for Pediatric Research 2017)
